With significant clinical results published in the Nature Medicine Journal, InBrain Pharma is about to durably modify the advanced Parkinson’s disease management
A World Premiere in Parkinson's Disease With significant clinical results published in the Nature Medicine Journal, InBrain Pharma is about to durably modify the advanced Parkinson's disease management A breakthrough therapeutic approach for Parkinson's disease: Anaerobic dopamine brain infusion1 Lille, January 27, 2024 – InBrain Pharma, a clinical stage biotech specialized in therapeutic solution development […]